Amarin Corp Plc (AMRN)

[Whalatane]

Ralph ...some pretty impressive results at Kidney wk for at least 1 SGLTi...Jardiance

Empagliflozin, sold under the brand name Jardiance among others, is an antidiabetic medication used to improve glucose control in people with type 2 diabetes, used to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease, used to reduce the risk of death and hospitalization in people with heart failure and low ejection fraction, and used to reduce the risk of cardiovascular death and hospitalization for heart failure in adults

Does have some risk ( UTI's) , not as safe as Vascepa and no benefit in reducing risk of revascularisations ( from what I've read ) .
Dont see why you wouldn't / couldn't add Vascepa to a stented CAD , diabetic with kidney disease patient .
Be interesting to see data on patients using a statin , Jardiance and Vascepa

https://investor.amarincorp.com/node/21676/pdf

A new post hoc sub-analysis of the landmark REDUCE-IT Study, published in the Journal of the American Heart Association (JAHA), found VASCEPA® significantly reduced the risk of cardiovascular death, strokes, heart attacks, coronary revascularization, and unstable angina by 34% in
patients with a history of percutaneous coronary intervention (PCI).

Hopefully RESPECT EPA will also publish data on prior MI patients

Kiwi